Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

4 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

1(20.0%)

Phase 4

1(20.0%)

5Total

N/A(3)

Phase 2(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT00283283Phase 2Completed

Comparison of Full-dose Flu Vaccine to Half-dose Flu Vaccine

Role: collaborator

NCT01538745Phase 4Completed

Low Dose Ketamine (LDK) Versus Morphine for Acute Pain Control in the Emergency Department

Role: collaborator

NCT00822692Not ApplicableCompleted

Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection

Role: collaborator

NCT00867425Not ApplicableCompleted

Translating the Diabetes Prevention Program Into a Virtual Lifestyle Management Program

Role: collaborator

NCT00409786Not ApplicableCompleted

Virtual Lifestyle Management: Prevention Through the UPMC Patient Portal

Role: collaborator

All 5 trials loaded